$1.4 Billion is the total value of First Light Asset Management, LLC's 79 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 35.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TNDM | Sell | TANDEM DIABETES CARE INC | $61,982,000 | +8.4% | 411,784 | -14.1% | 4.44% | +17.8% |
| ARNA | Sell | ARENA PHARMACEUTICALS INC | $60,025,000 | +56.0% | 645,848 | -0.0% | 4.30% | +69.6% |
| OMCL | Sell | OMNICELL INC | $55,015,000 | +4.7% | 304,895 | -13.9% | 3.94% | +13.8% |
| XENT | Sell | INTERSECT ENT INC | $46,368,000 | -20.2% | 1,697,834 | -20.5% | 3.32% | -13.3% |
| RARE | Sell | ULTRAGENYX PHARMACEUTICAL INC | $34,587,000 | -13.1% | 411,313 | -6.8% | 2.48% | -5.5% |
| CDNA | Sell | CAREDX INC | $31,084,000 | -45.5% | 683,463 | -24.1% | 2.23% | -40.8% |
| CUTR | Sell | CUTERA INC | $27,142,000 | -24.2% | 656,873 | -14.6% | 1.94% | -17.6% |
| NEO | Sell | NEOGENOMICS INC | $26,065,000 | -48.8% | 763,907 | -27.7% | 1.87% | -44.4% |
| OPRX | Sell | OPTIMIZERX CORP | $19,488,000 | -55.1% | 313,769 | -38.2% | 1.40% | -51.2% |
| INSM | Sell | INSMED INC | $19,024,000 | -43.7% | 698,369 | -43.1% | 1.36% | -38.8% |
| TEVA | Sell | TEVA PHARMACEUTICAL IND | $15,199,000 | -40.5% | 1,897,506 | -27.7% | 1.09% | -35.4% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $11,290,000 | -17.3% | 127,785 | -27.6% | 0.81% | -10.0% |
| ITMR | Sell | ITAMAR MEDICAL LTD | $10,972,000 | -45.2% | 355,410 | -46.4% | 0.79% | -40.5% |
| AXNX | Sell | AXONICS MODULATION TECHNOLOGIES | $7,602,000 | -65.8% | 135,752 | -60.3% | 0.54% | -62.9% |
| GMAB | Sell | GENMAB AS | $6,288,000 | -44.4% | 158,947 | -38.6% | 0.45% | -39.7% |
| ANNX | Sell | ANNEXON BIOSCIENCES INC | $5,443,000 | -39.5% | 473,700 | -2.1% | 0.39% | -34.2% |
| MRVI | Sell | MARAVAI LIFE SCIENCES | $4,049,000 | -30.5% | 96,637 | -18.6% | 0.29% | -24.5% |
| JYNT | Sell | THE JOINT CORP | $3,643,000 | -33.1% | 55,452 | -0.1% | 0.26% | -27.3% |
| SLP | Sell | SIMULATIONS PLUS INC | $3,549,000 | +19.6% | 75,023 | -0.1% | 0.25% | +30.3% |
| LHCG | Sell | LHC GROUP INC | $2,089,000 | -12.7% | 15,219 | -0.3% | 0.15% | -5.1% |
| EBS | Exit | EMERGENT BIOSOLUTIONS INC | $0 | – | -4,294 | -100.0% | -0.01% | – |
| HRC | Exit | HILL ROM HOLDINGS | $0 | – | -4,346 | -100.0% | -0.04% | – |
| RLAY | Exit | RELAY THERAPEUTICS INC | $0 | – | -51,848 | -100.0% | -0.11% | – |
| TCRR | Exit | TCR2 THERAPEUTICS INC | $0 | – | -620,887 | -100.0% | -0.35% | – |
| NVTA | Exit | INVITAE CORPORATION | $0 | – | -256,367 | -100.0% | -0.48% | – |
| WW | Exit | WW INTERNATIONAL INC | $0 | – | -458,273 | -100.0% | -0.55% | – |
| Exit | APTOSE BIOSCIENCES INC | $0 | – | -4,128,443 | -100.0% | -0.59% | – | |
| STIM | Exit | NEURONETICS INC | $0 | – | -1,458,818 | -100.0% | -0.63% | – |
| YMAB | Exit | Y-MABS THERAPEUTICS INC | $0 | – | -577,663 | -100.0% | -1.09% | – |
| XBI | Exit | SPDR S&P BIOTECH ETF | $0 | – | -204,600 | -100.0% | -1.70% | – |
| ALDX | Exit | ALDEYRA THERAPEUTICS INC | $0 | – | -2,985,712 | -100.0% | -1.73% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ATRICURE INC | 40 | Q3 2023 | 9.7% |
| NEOGENOMICS INC | 40 | Q3 2023 | 10.6% |
| SANOFI-SYNTHELABO | 40 | Q3 2023 | 1.9% |
| JOHNSON & JOHNSON | 40 | Q3 2023 | 0.3% |
| PFIZER INC | 39 | Q2 2023 | 0.9% |
| BIOMARIN PHARMACEUTICAL INC | 36 | Q3 2023 | 1.6% |
| OMNICELL INC | 33 | Q3 2023 | 7.7% |
| QUIDEL CORP | 33 | Q4 2021 | 3.7% |
| NOVARTIS AG-SPONSORED ADR | 33 | Q3 2023 | 0.4% |
| MODEL N INC | 30 | Q3 2023 | 9.0% |
View First Light Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| REATA PHARMACEUTICALS INC | May 15, 2023 | 1,290,193 | 3.9% |
| Axogen, Inc. | February 03, 2023 | 1,942,270 | 4.6% |
| MODEL N, INC. | February 03, 2023 | 1,845,134 | 4.9% |
| MEI Pharma, Inc.Sold out | May 31, 2022 | 0 | 0.0% |
| PROTHENA CORP PUBLIC LTD CO | March 01, 2022 | 1,805,038 | 3.9% |
| Intersect ENT, Inc. | February 14, 2022 | 1,375,210 | 4.1% |
| SeaSpine Holdings Corp | February 14, 2022 | 6,847,707 | 18.8% |
| Oxford Immunotec Global PLCSold out | February 10, 2021 | 0 | 0.0% |
| ENDOLOGIX INC /DE/ | February 14, 2020 | 816,236 | 4.6% |
| Nuvectra CorpSold out | February 14, 2020 | 0 | 0.0% |
View First Light Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-09 |
| 4 | 2024-04-08 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
View First Light Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.